Patient Recruitment- Key to New Treatment Development

Because finding patients for new treatments in the rare disease sector can be challenging, more techniques for both recruiting patient and making the clinical trials accessible are discussed here. As Harsha Murthy states, "It's critical for patients to have these kinds of conversations" as they consider clinical trials.
This continuing panel discussion, "Breaking Down Barriers in Product Development features these speakers:
Harsha Murthy as moderator, Managing Partner, Consummate Capital
Dr. Peter Marks, MD, PhD, Director, Center for Biologics Evaluation and Research, FDA
Jay Backstrom, MD, MPH – Chief Medical Officer, Celgene
Jodie Gillon, Global Medical Lead, Patient Engagement Rare Diseases at Pfizer
Be sure to view the entire discussion on the AAMDSIF channel, the Coalition for Bone Marrow Failure Diseases playlist.
#AAMDSIF #MarrowStrong